HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pravastatin: an evidence-based statin?

AbstractBACKGROUND:
It is well known that statins lead to a markable reduction in cardiovascular morbidity and mortality. One of the first and best studied statins is pravastatin, which has been studied in both primary and secondary prevention trials. With 40 mg pravastatin daily, total cholesterol can be reduced by 25-34% with a very consistent risk reduction of 24% of death from cardiovascular diseases. Side effects are rare and usually consist of myopathy. Following the Adult Treatment Panel III (ATPIII) guidelines on cholesterol management, apart from therapeutic lifestyle changes, in high-risk patients (including patients with diabetes mellitus), cholesterol-lowering therapy should be targeted at a treatment goal of LDL cholesterol<2.5 mmol/l. Statin-lowering therapy should be commenced to adequately lower cardiovascular risk. Therefore, when the expected 25-34% LDL cholesterol lowering would be enough to reach an LDL<2.5 mmol/l, treatment should be started with pravastatin.
METHOD:
Trials have shown that treatment with pravastatin is safe in older patients as well as in children with familial hypercholesterolemia.
RESULTS/CONCLUSION:
Since obesity seems to become a worldwide problem and given the low costs of generic pravastatin, it may even be cost-effectively used in developing countries.
AuthorsAntonio Iglesias del Sol, Prabath W B Nanayakkara
JournalExpert opinion on drug metabolism & toxicology (Expert Opin Drug Metab Toxicol) Vol. 4 Issue 6 Pg. 821-5 (Jun 2008) ISSN: 1742-5255 [Print] England
PMID18611121 (Publication Type: Journal Article, Review)
Chemical References
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pravastatin
Topics
  • Atherosclerosis (complications, drug therapy)
  • Cardiovascular Diseases (etiology, prevention & control)
  • Evidence-Based Medicine
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors (adverse effects, therapeutic use)
  • Hypercholesterolemia (complications, drug therapy)
  • Practice Guidelines as Topic
  • Pravastatin (adverse effects, therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: